The firm has a negative working capital of nearly $1 million. The post Psyence reports no revenue in Q4, but returns a profit appeared first on...
The psychoactive compound, MEAI, is dubbed a "binge mitigating agent." The post Clearmind trials new alcohol disorder fix appeared first on Green Market...
Clearmind Medicine Inc., a name synonymous with innovation in the pharmaceutical sector, recently marked a significant milestone in its journey towards...
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company...
In the mid-20th century, psychedelic substances like LSD were explored for treating mood disorders and alcohol dependence. Their association with the 1960s...
New potential therapies like MDMA will need more infrastructure beyond just buildings. The post Prepping the psychedelic industry for MDMA approval appeared...
Whether you are taking a solo journey or spending a weekend in ceremony, knowing how to prepare for a psychedelic trip is invaluable to the outcome.
VANCOUVER, BC, Feb. 1, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company...
Numinus Wellness Inc. (OTCQX: NUMIF) has successfully orchestrated a financing strategy to secure $6 million by entering into a definitive agreement for...
The financing drew support from a cohort that includes MAPS. The post Investors rally behind Numinus Wellness in a $6M bought deal appeared first on Green...